| Medical and Health Sciences | Lifetime | 919 | US 475 | 99.96 |
| Pathology and Forensic Medicine | Lifetime | 25 | US 14 | 99.90 |
| Medical Genetics | Lifetime | 86 | US 49 | 99.35 |
| Hematology | Lifetime | 168 | US 88 | 99.03 |
| Oncology | Lifetime | 536 | US 296 | 99.01 |
| Pathology and Forensic Medicine | 2021-2025 | 144 | US 56 | 96.37 |
| Oncology | 2021-2025 | 960 | US 403 | 82.59 |
| Medical Genetics | 2021-2025 | 342 | US 158 | 75.70 |
| Lymphoma Diagnosis and Treatment | Lifetime | 7 | US 5 | 99.92 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 25 | US 18 | 99.88 |
| Multiple Myeloma Research and Treatments | Lifetime | 31 | US 17 | 99.78 |
| Viral-associated cancers and disorders | Lifetime | 36 | US 18 | 99.59 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 190 | US 124 | 99.60 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 93 | US 55 | 99.21 |
| CAR-T cell therapy research | Lifetime | 139 | US 84 | 99.48 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 61 | US 28 | 99.06 |
| Protein Degradation and Inhibitors | Lifetime | 170 | US 101 | 98.63 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 595 | US 303 | 98.69 |
| Cancer Treatment and Pharmacology | Lifetime | 496 | US 254 | 98.60 |
| Peptidase Inhibition and Analysis | Lifetime | 654 | US 300 | 97.83 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 294 | US 179 | 97.60 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 578 | US 247 | 97.63 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 210 | US 93 | 97.71 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 229 | US 110 | 97.10 |
| T-cell and Retrovirus Studies | Lifetime | 798 | US 345 | 93.87 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 952 | US 372 | 93.89 |
| Chemokine receptors and signaling | Lifetime | 721 | US 275 | 91.75 |
| Hematological disorders and diagnostics | Lifetime | 906 | US 393 | 90.44 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 423 | US 98 | 88.98 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 216 | US 111 | 97.82 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 96 | US 42 | 93.67 |
| Viral-associated cancers and disorders | 2021-2025 | 170 | US 85 | 93.60 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 791 | US 327 | 92.49 |
| T-cell and Retrovirus Studies | 2021-2025 | 672 | US 143 | 66.40 |
| Histiocytic Disorders and Treatments | 2021-2025 | 570 | US 211 | 47.06 |
| Magnesium in Health and Disease | 2021-2025 | 955 | US 192 | 20.68 |
